StockData
GH Research PLC logo

GH Research PLC (GHRS) stock

GHRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$18.25−0.02 (-0.11%)

Close on Nov 18, 2026Market cap $1.13BP/E –Yield –

GH Research operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

GH Research's operating cash flow for the twelve months ending Jun 30, 2026 was -$51.70M. For fiscal 2025 it was -$43.55M. The highest annual figure on record is -$289.00K in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$43.55M–
FY2024Dec 31, 2024-$42.29M–
FY2023Dec 31, 2023-$33.34M–
FY2022Dec 31, 2022-$26.20M–
FY2021Dec 31, 2021-$15.28M–
FY2020Dec 31, 2020-$330.00K–
FY2019Dec 31, 2019-$289.00K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$15.02M–
Q1 FY2026Mar 31, 2026-$10.67M–
Q4 FY2025Dec 31, 2025-$12.33M–
Q3 FY2025Sep 30, 2025-$13.68M–
Q2 FY2025Jun 30, 2025-$8.97M–
Q1 FY2025Mar 31, 2025-$8.57M–
Q4 FY2024Dec 31, 2024-$10.45M–
Q3 FY2024Sep 30, 2024-$12.31M–
Q2 FY2024Jun 30, 2024-$9.94M–
Q1 FY2024Mar 31, 2024-$9.60M–
Q4 FY2023Dec 31, 2023-$8.09M–
Q3 FY2023Sep 30, 2023-$10.34M–
Q2 FY2023Jun 30, 2023-$8.03M–
Q1 FY2023Mar 31, 2023-$6.89M–
Q4 FY2022Dec 31, 2022-$6.87M–
Q3 FY2022Sep 30, 2022-$8.05M–

More GH Research figures

See a number that looks wrong?